1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow rAAV9.CMV.hNAGLU: new trials by email Literature Review of rAAV9.CMV.hNAGLU trials Research Report on rAAV9.CMV.hNAGLU
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gene Transfer Clinical Trial for Mucopolysaccharidosis (MPS) IIIB rAAV9.CMV.hNAGLU - Mucopolysaccharidosis Type 3 B | Phase 1 / Phase 2 | Terminated | Abeona Therapeutics, Inc | 11 | 2017-10-16 | 2022-05-05 |
France (1) · Germany (1) · Spain (1) · United States (1)